A case report of combination treatment with potassium-titanyl phosphate laser and brimonidine topical gel in erythematotelangiectatic rosacea

2017 ◽  
Vol 19 (4) ◽  
pp. 222-224 ◽  
Author(s):  
Maja A. Hofmann ◽  
G. Kokolakis
2008 ◽  
Vol 122 (12) ◽  
pp. 1377-1380 ◽  
Author(s):  
H Kouzaki ◽  
J Fukui ◽  
T Shimizu

AbstractObjective:To report the safe management and treatment of a catecholamine-secreting tympanicum glomus tumour.Case report:A 73-year-old women presented with a catecholamine-producing glomus tympanicum tumour, complaining of hearing impairment and left ear pain. Physical examination revealed a red, pulsating swelling in the left tympanic membrane. Computed tomography demonstrated a soft tissue mass filling the entire middle-ear cavity and a partial osteolytic lesion in the internal carotid artery. Angiographic examination revealed a densely contrasting tumour with feeding vessels from the ascending pharyngeal artery. Concentrations of serum noradrenalin and urine vanillylmandelic acid (VMA) were high. The tumour was completely resected using a potassium titanyl phosphate laser, the feeding vessels having been embolised the previous day. Concentrations of serum noradrenalin and urine VMA normalised following the operation.Conclusion:Pre-operative embolisation is useful in the treatment of catecholamine-secreting tympanicum glomus tumours, not only for preventing a hypertensive crisis but also for reducing bleeding. The potassium titanyl phosphate laser is useful for complete resection of the tumour.


2005 ◽  
Vol 174 (3) ◽  
pp. 1110-1114 ◽  
Author(s):  
ALIREZA MOINZADEH ◽  
INDERBIR S. GILL ◽  
MAURICIO RUBENSTEIN ◽  
OSAMU UKIMURA ◽  
MONISH ARON ◽  
...  

2009 ◽  
Vol 124 (4) ◽  
pp. 407-411 ◽  
Author(s):  
J A Burns ◽  
A D Friedman ◽  
M J Lutch ◽  
R E Hillman ◽  
S M Zeitels

AbstractObjectives:Recently, the 532 nm pulsed potassium-titanyl-phosphate laser has emerged as an effective angiolytic laser for treating mucosal lesions of the larynx in the operating theatre and clinic. We sought to assess the current impact of potassium-titanyl-phosphate laser on our laryngeal surgery practice.Study design:Retrospective review of 710 patients undergoing endoscopic laryngeal surgery over a one-year period.Methods:Medical records of the endoscopic laryngeal procedures were reviewed; 386/710 had been performed in the clinic and 324/710 in the operating theatre under general anaesthesia. Indications for the procedures were classified by pathology.Results:Pulsed potassium-titanyl-phosphate laser was used in 209/386 clinic procedures. The indications for these procedures were: dysplasia (114/209 procedures), papillomatosis (89/209), varices or ectasia (three of 209), and ‘other’ (three of 209). Pulsed potassium-titanyl-phosphate laser was used in 178/324 operating theatre endoscopic laryngeal procedures. The indications for these procedures were: cancer (54/178 procedures), dysplasia (52/178), papillomatosis (38/178), varices or ectasia (13/178), polyps (six of 178), nodules (six of 178), stenosis (five of 178), granulation (three of 178), and amyloid (one of 178).Conclusions:Due to its versatility, the 532 nm pulsed potassium-titanyl-phosphate laser is our most commonly utilised instrument for performing endoscopic laryngeal surgery.


Sign in / Sign up

Export Citation Format

Share Document